Sammy Zwackman

Publications

2026

Sacharias Von Koch, Tania Sharma, Ramzi Khamis, Tomas Jernberg, Stefan James, Elmir Omerovic, Sammy Zwackman, Johan Sjogren, David Erlinge, Moman A. Mohammad (2026)

Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome: a case-crossover study from SCAAR The Lancet Regional Health: Europe, Vol. 60, Article 101507 (Article in journal)

https://dx.doi.org/10.1016/j.lanepe.2025.101507

2025

Sacharias von Koch, Johannes Todt, Mikael Zhou, Petur Petursson, Jonas Persson, Juliane Jurga, Sammy Zwackman, Giovanna Sarno, Sasha Koul, David Erlinge, Moman A. Mohammad (2025)

Drug-coated balloons versus drug-eluting stents for small non-complex de novo coronary artery lesions: A segment-level propensity score matched analysis from SCAAR Cardiovascular Revascularization Medicine, Vol. 80, p. 88-95 (Article in journal)

https://dx.doi.org/10.1016/j.carrev.2025.04.006

Sammy Zwackman (2025)

Management, prevention and outcome of myocardial infarction in native vs foreign-born patients (Doctoral thesis, comprehensive summary)

https://dx.doi.org/10.3384/9789180759441

Karolina Berntorp, Moman A. Mohammad, Sasha Koul, Troels Yndigegn, Sofia Bergman, Sammy Zwackman, Rikard Linder, Sebastian Volz, Ole Frobert, David Erlinge, Matthias Gotberg (2025)

Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry International Journal of Cardiology, Vol. 419, Article 132726 (Article in journal)

https://dx.doi.org/10.1016/j.ijcard.2024.132726

2024

David Erlinge, Jonas Andersson, Ole Frobert, Mattias Tornerud, Mehmet Hamid, Thomas Kellerth, Per Grimfjard, Oscar Winnberg, Juliane Jurga, Henrik Wagner, Sammy Zwackman, Martin Adielsson, Patrik Alstrom, Elli Masoe, Anders Ulvenstam, Jonas Millgard, Felix Bohm, Claes Held, Henrik Renlund, Jonas Oldgren, Pieter C. Smits, Candace Elek, Andrea Abizaid, Stefan James (2024)

Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial The Lancet, Vol. 404, p. 1750-1759 (Article in journal)

https://dx.doi.org/10.1016/S0140-6736(24)02227-X

News

Healthcare interpreters important for heart attack aftercare

After a heart attack, foreign-born people are less likely to attend a relapse-preventing Heart School than native-born patients. But with access to a professional interpreter, participation increases, according to a new study.